An international team developed M-PACT, an AI-powered tool, to classify pediatric brain tumors using liquid biopsy samples with high accuracy.
Key Details
- 1M-PACT uses AI to classify brain tumors from small amounts of circulating tumor DNA in cerebrospinal fluid.
- 2Achieved 92% accuracy in benchmarking tests for classifying brain tumors.
- 3Applicable for diagnosis, monitoring treatment response, and identifying recurrences or secondary malignancies.
- 4Utilizes deep neural network trained on over 5,000 DNA methylation profiles across ~100 tumor types.
- 5Provides new insights into tumor microenvironment by analyzing cell-type contributions.
- 6Published in Nature Cancer by a collaboration led by St. Jude Children's Research Hospital.
Why It Matters
This advance enables less invasive, highly accurate classification of pediatric brain tumors, helping personalize and improve treatment while lowering the need for surgical biopsies. The AI framework could extend to other cancers, signaling a major shift in molecular cancer diagnostics.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.